NexImmune Current Ratio 2020-2024 | NEXI

NexImmune current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

NexImmune Current Ratio 2020-2024 | NEXI

NexImmune current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$145.5B
Vertex Pharmaceuticals (VRTX)$119.4B
Gilead Sciences (GILD)$114.5B
Bristol Myers Squibb (BMY)$113.1B
CSL (CSLLY)$84.9B
Regeneron Pharmaceuticals (REGN)$80.4B
GSK (GSK)$70.4B
Argenex SE (ARGX)$36.7B
Alnylam Pharmaceuticals (ALNY)$31.7B
BioNTech SE (BNTX)$28.6B
Illumina (ILMN)$22.8B
Biogen (BIIB)$21.9B
BeiGene (BGNE)$17.5B
Moderna (MRNA)$16.1B
Genmab (GMAB)$13.3B
Incyte (INCY)$13.2B
Insmed (INSM)$12.8B
BioMarin Pharmaceutical (BMRN)$12.6B
Bio-Techne Corp (TECH)$12B
Sarepta Therapeutics (SRPT)$11.8B
Exact Sciences (EXAS)$11.3B
Vaxcyte (PCVX)$10.9B
QIAGEN (QGEN)$10.4B
Exelixis (EXEL)$10B
Bio-Rad Laboratories (BIO.B)$9.4B
Intra-Cellular Therapies (ITCI)$8.8B
Repligen (RGEN)$8.8B
Roivant Sciences (ROIV)$8.6B
Ascendis Pharma (ASND)$7.9B
Revolution Medicines (RVMD)$7.6B